Prognostic implication of isolated tumor cells and micrometastases in regional lymph nodes of gastric cancer

World Journal of Gastroenterology

Volumn 11, Issue 38, 2005, Pages 5920-5925

  Lee, Hye Seung ^a   Kim, Min A ^b   Yang, Han Kwang ^b   Lee, Byung Lan ^b   Kim, Woo Ho ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Cytokeratin; Immunohistochemistry; Lymph node metastasis; Patient survival

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN;

CANCER CLASSIFICATION; CANCER SIZE; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOLATED TUMOR CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; REVIEW; STOMACH CANCER; TUMOR CELL;

EID: 28644438800     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i38.5920     Document Type: Review

References (24)

1. Adachi Y, Kamakura T, Mori M, Baba H, Maehara Y, Sugimachi K. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994; 81: 414-416
2. Isozaki H, Okajima K, Fujii K. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy. Hepatogastroenterology 1997; 44: 1133-1136
3. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet 1990; 335: 1565-1568
4. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999; 354: 896-900
5. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997; 80: 1188-1197
6. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, Sugarbaker DJ, Odze RD. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999; 85: 769-778
7. Doki Y, Ishikawa O, Mano M, Hiratsuka M, Sasaki Y, Kameyama M, Ohigashi H, Murata K, Yamada T, Miyashiro I, Yokoyama S, Ishiguro S, Imaoka S. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res 2002; 107: 75-81
8. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223-228
9. Nicholson AG, Marks CG, Cook MG. Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut 1994; 35: 1447-1448
10. American Joint Committee on Cancer. AJCC cancer staging manual 6th ed. New York: Springer-Verlag, 2002
11. International Agency for Research on Cancer (IARC). World Health Organization Classification of Tumors; pathology and genetics of tumors of the digestive system. Lyon: IARC Press, 2000
12. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95: 108-113
13. Kumar V, Abbas AK, Fausto N. Robbins and Cotran pathologic basis of disease 7th ed. Philadelphia: Elsevier, 2004
14. Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer 1961; 14: 1266-1271
15. Morgagni P, Saragoni L, Scarpi E, Zattini PS, Zaccaroni A, Morgagni D, Bazzocchi F. Lymph node micrometastases in early gastric cancer and their impact on prognosis. World J Surg 2003; 27: 558-561
16. Choi HJ, Kim YK, Kim YH, Kim SS, Hong SH. Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma. Ann Surg Oncol 2002; 9: 13-19
17. Fukagawa T, Sasako M, Mann GB, Sano T, Katai H, Maruyama K, Nakanishi Y, Shimoda T. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 2001; 92: 753-760
18. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takenchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002; 9: 771-774
19. Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer 2002; 94: 2867-2873
20. Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, Baba M, Takao S, Aikou T. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 2001; 8: 158-162
21. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997; 79: 1069-1076
22. Xu X, Roberts SA, Pasha TL, Zhang PJ. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 2000; 124: 1310-1313
23. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994; 73: 563-569
24. Gould VE, Bloom KJ, Franke WW, Warren WH, Moll R. Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch 1995; 425: 617-629